Shows & Panels
- The 2014 Big Picture on Cyber Security
- AFCEA Answers
- Ask the CIO
- Building the Hybrid Cloud
- Connected Government: How to Build and Procure Network Services for the Future
- Continuing Diagnostics and Mitigation: Discussion of Progress and Next Steps
- Federal Executive Forum
- Federal Tech Talk
- The Future of Government Data Centers
- The Future of IT: How CIOs Can Enable the Service-Oriented Enterprise
- The Intersection: Where Technology Meets Transformation
- Maximizing ROI Through Data Center Consolidation
- Mitigating Insider Threats in Virtual & Cloud Environments
- Modern Mission Critical Series
- Moving to the Cloud. What's the best approach for me
- Navigating Tough Choices in Government Cloud Computing
- The New Generation of Database
- Satellite Communications: Acquiring SATCOM in Tight Times
- Targeting Advanced Threats: Proven Methods from Detection through Remediation
- Transformative Technology: Desktop Virtualization in Government
- The Truth About IT Opex and Software Defined Networking
- Value of Health IT
- Air Traffic Management Transformation Report
- Cloud First Report
- General Dynamics IT Enterprise Center
- Gov Cloud Minute
- Government in Technology Series
- Homeland Security Cybersecurity Market Report
- National Cybersecurity Awareness Month
- Technology Insights
- The Cyber Security Report
- The Next Generation Cyber Security Experts
Shows & Panels
Competitor's woes buffet Monster's stock
Thursday - 11/15/2012, 4:57pm EST
AP Business Writer
PORTLAND, Ore. (AP) - Monster Beverage Corp.'s stock was buffeted Thursday by the news that the Food and Drug Administration is investigating deaths potentially tied to a competitor's product.
The Corona, Calif.-based company's stock fell more than 5 percent in early trading. But by the end of the day on Wall Street, it had recovered all the lost ground and finished with a slight gain.
In the latest in a string of bad news for energy-drink makers, the FDA said it is investigating reports of 13 deaths of people who took 5-Hour Energy beverage shots made by Living Essentials.
The federal agency says it has received 92 reports, including 33 hospitalizations and 13 deaths, after consumers drank 5-Hour Energy. These reports claim that people suffered adverse reactions after consuming the products, but do not prove that the drink was the cause.
FDA officials said they will take action if they can link the deaths to consumption of the energy drink, which could include forcing the company to take the drinks off the market.
Energy-drink makers are facing intense scrutiny following reports and lawsuits that allege the highly-caffeinated products are tied to deaths.
In October, the FDA said it was investigating reports of five deaths in which the consumption of Monster drinks were cited. Those claims also do not necessarily prove that the drink was the cause. Monster was also sued in October by the parents of a teenager who died after drinking two 24-ounce energy drinks within a 24-hour period.
In August, New York state Attorney General Eric Schneiderman issued subpoenas to Monster and other energy-drink makers as part of the state's investigation of the industry. U.S. Senators Dick Durbin and Richard Blumenthal have also asked the FDA to take another look at the effect that caffeine and other ingredients in energy drinks have on children and adolescents.
The company has repeatedly said its drinks are safe and it does not know of any fatalities caused by its products.
The label on Monster's drinks state that they are not recommended for children and people who are sensitive to caffeine. Monster says its drinks generally contain about 10 milligrams of caffeine per ounce _ about half the amount in coffee.
"There is not a shred of information of which causally links Monster to these adverse events and the ... lawsuit is the first the company has ever received," CEO Rodney Sacks told investors during its most recent quarterly earnings call.
Monster's stock has lost more than 40 percent of its value since this summer. The company declined to comment Thursday.
Morningstar analyst Tom Mullarkey says the recent market decline is overblown. The analyst said that company has made it clear that it believes its products are safe and the FDA has not found that the products are tied to any deaths. Mullarkey also said that Monster's drinks remain popular. While consumers may take pause temporarily when they hear such news, they continue to buy the drink.
"I think Monster's long-term growth prospects are still intact," Mullarkey said Thursday.
Monster's stock closed the day up 7 cents at $44.81. It dipped about 1 percent in after-hours trading to $44.30.
Associated Press writer Mary Clare Jalonick contributed to this report.
(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)